These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38632525)

  • 1. Characterization of early markers of disease in the mouse model of mucopolysaccharidosis IIIB.
    McCullough KB; Titus A; Reardon K; Conyers S; Dougherty JD; Ge X; Garbow JR; Dickson P; Yuede CM; Maloney SE
    J Neurodev Disord; 2024 Apr; 16(1):16. PubMed ID: 38632525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Neurobehavioral Phenotype in Mucopolysaccharidosis Type IIIB: an Exploratory Study.
    Shapiro E; King K; Ahmed A; Rudser K; Rumsey R; Yund B; Delaney K; Nestrasil I; Whitley C; Potegal M
    Mol Genet Metab Rep; 2016 Mar; 6():41-47. PubMed ID: 26918231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal MRI brain volume changes over one year in children with mucopolysaccharidosis types IIIA and IIIB.
    Abreu NJ; Selvaraj B; Truxal KV; Moore-Clingenpeel M; Zumberge NA; McNally KA; McBride KL; Ho ML; Flanigan KM
    Mol Genet Metab; 2021 Jun; 133(2):193-200. PubMed ID: 33962822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Femoral Structure and Biomechanical Characteristics in Sanfilippo Syndrome Type-B Mice.
    Ashby FJ; Castillo EJ; Ludwig Y; Andraka NK; Chen C; Jamieson JC; Kabbej N; Sommerville JD; Aguirre JI; Heldermon CD
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tralesinidase Alfa Enzyme Replacement Therapy Prevents Disease Manifestations in a Canine Model of Mucopolysaccharidosis Type IIIB.
    Ellinwood NM; Valentine BN; Hess AS; Jens JK; Snella EM; Jamil M; Hostetter SJ; Jeffery ND; Smith JD; Millman ST; Parsons RL; Butt MT; Chandra S; Egeland MT; Assis AB; Nelvagal HR; Cooper JD; Nestrasil I; Mueller BA; Labounek R; Paulson A; Prill H; Liu XY; Zhou H; Lawrence R; Crawford BE; Grover A; Cherala G; Melton AC; Cherukuri A; Vuillemenot BR; Wait JCM; O'Neill CA; Pinkstaff J; Kovalchin J; Zanelli E; McCullagh E
    J Pharmacol Exp Ther; 2022 Sep; 382(3):277-286. PubMed ID: 35717448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of sensory, motor and behavioral deficits in the murine model of Sanfilippo syndrome type B.
    Heldermon CD; Hennig AK; Ohlemiller KK; Ogilvie JM; Herzog ED; Breidenbach A; Vogler C; Wozniak DF; Sands MS
    PLoS One; 2007 Aug; 2(8):e772. PubMed ID: 17712420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A model of mucopolysaccharidosis IIIB (Sanfilippo syndrome type IIIB): N-acetyl-alpha-D-glucosaminidase deficiency in Schipperke dogs.
    Ellinwood NM; Wang P; Skeen T; Sharp NJ; Cesta M; Decker S; Edwards NJ; Bublot I; Thompson JN; Bush W; Hardam E; Haskins ME; Giger U
    J Inherit Metab Dis; 2003; 26(5):489-504. PubMed ID: 14518829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical evaluation of intracerebroventricular rhNAGLU-IGF2 enzyme replacement therapy in neonatal mice with Sanfilippo B syndrome.
    Kan SH; Elsharkawi I; Le SQ; Prill H; Mangini L; Cooper JD; Lawrence R; Sands MS; Crawford BE; Dickson PI
    Mol Genet Metab; 2021 Jun; 133(2):185-192. PubMed ID: 33839004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated clinical disease and pathology in mucopolysaccharidosis type IIIB and GalNAc transferase double knockout mice.
    Mohammed EE; Snella EM; Rutz-Mendicino MM; Echevarria FD; Awedikian R; Whitley EM; Ellinwood NM
    Mol Genet Metab; 2012 Sep; 107(1-2):129-35. PubMed ID: 22867887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central nervous system pathology in preclinical MPS IIIB dogs reveals progressive changes in clinically relevant brain regions.
    Egeland MT; Tarczyluk-Wells MM; Asmar MM; Adintori EG; Lawrence R; Snella EM; Jens JK; Crawford BE; Wait JCM; McCullagh E; Pinkstaff J; Cooper JD; Ellinwood NM
    Sci Rep; 2020 Nov; 10(1):20365. PubMed ID: 33230178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease pathology signatures in a mouse model of Mucopolysaccharidosis type IIIB.
    Petrova R; Patil AR; Trinh V; McElroy KE; Bhakta M; Tien J; Wilson DS; Warren L; Stratton JR
    Sci Rep; 2023 Oct; 13(1):16699. PubMed ID: 37794029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological and Histological Characterization of Rod-Cone Retinal Degeneration and Microglia Activation in a Mouse Model of Mucopolysaccharidosis Type IIIB.
    Tse DY; Lotfi P; Simons DL; Sardiello M; Wu SM
    Sci Rep; 2015 Nov; 5():17143. PubMed ID: 26607664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporospatial Development of Neuropathologic Findings in a Canine Model of Mucopolysaccharidosis IIIB.
    Harm TA; Hostetter SJ; Nenninger AS; Valentine BN; Ellinwood NM; Smith JD
    Vet Pathol; 2021 Jan; 58(1):205-222. PubMed ID: 33205707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic Analysis of Mucopolysaccharidosis IIIB Mouse Brain.
    De Pasquale V; Costanzo M; Siciliano RA; Mazzeo MF; Pistorio V; Bianchi L; Marchese E; Ruoppolo M; Pavone LM; Caterino M
    Biomolecules; 2020 Feb; 10(3):. PubMed ID: 32111039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage enzyme and reduced inflammation drive brain correction of mucopolysaccharidosis IIIB by stem cell gene therapy.
    Holley RJ; Ellison SM; Fil D; O'Leary C; McDermott J; Senthivel N; Langford-Smith AWW; Wilkinson FL; D'Souza Z; Parker H; Liao A; Rowlston S; Gleitz HFE; Kan SH; Dickson PI; Bigger BW
    Brain; 2018 Jan; 141(1):99-116. PubMed ID: 29186350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential distribution of heparan sulfate glycoforms and elevated expression of heparan sulfate biosynthetic enzyme genes in the brain of mucopolysaccharidosis IIIB mice.
    McCarty DM; DiRosario J; Gulaid K; Killedar S; Oosterhof A; van Kuppevelt TH; Martin PT; Fu H
    Metab Brain Dis; 2011 Mar; 26(1):9-19. PubMed ID: 21225451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucopolysaccharidosis III in Mainland China: natural history, clinical and molecular characteristics of 34 patients.
    Kong W; Meng Y; Zou L; Yang G; Wang J; Shi X
    J Pediatr Endocrinol Metab; 2020 May; 33(6):793-802. PubMed ID: 32447333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological correction of lysosomal storage in a mucopolysaccharidosis IIIB mouse model by adeno-associated virus-mediated gene delivery.
    Fu H; Samulski RJ; McCown TJ; Picornell YJ; Fletcher D; Muenzer J
    Mol Ther; 2002 Jan; 5(1):42-9. PubMed ID: 11786044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic efficacy of bone marrow transplant, intracranial AAV-mediated gene therapy, or both in the mouse model of MPS IIIB.
    Heldermon CD; Ohlemiller KK; Herzog ED; Vogler C; Qin E; Wozniak DF; Tan Y; Orrock JL; Sands MS
    Mol Ther; 2010 May; 18(5):873-80. PubMed ID: 20179679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease modeling for Mucopolysaccharidosis type IIIB using patient derived induced pluripotent stem cells.
    Huang W; Cheng YS; Yang S; Swaroop M; Xu M; Huang W; Zheng W
    Exp Cell Res; 2021 Oct; 407(1):112785. PubMed ID: 34411609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.